These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1078314)

  • 21. Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
    Angelkort B; Kiesewetter H
    Scand J Clin Lab Invest Suppl; 1981; 156():185-8. PubMed ID: 6948383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
    Störmer B; Kleinschmidt F; Loose D; Kremer K
    Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentoxifylline and intermittent claudication.
    Spittel JA
    Ann Intern Med; 1985 Jan; 102(1):126-7. PubMed ID: 3966730
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of pentoxifylline on cell shape, ATP content and deformability in rabbit erythrocytes under hyperosmolar conditions.
    Nishio T; Toshima Y; Matsuno Y
    Int J Biochem; 1982; 14(10):915-20. PubMed ID: 7128909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic lowering of fibrinogen levels].
    Ernst E
    MMW Munch Med Wochenschr; 1983 May; 125(21):83-4. PubMed ID: 6410202
    [No Abstract]   [Full Text] [Related]  

  • 26. Haemorheological effects of fructose-1,6-diphosphate in patients with lower extremity ischaemia.
    Cacioli D; Clivati A; Pelosi P; Megevand J; Galeone M
    Curr Med Res Opin; 1988; 10(10):668-74. PubMed ID: 3371082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional vascular disorders: treatment with pentoxifylline.
    Neirotti M; Longo F; Molaschi M; Macchione C; Pernigotti L
    Angiology; 1987 Aug; 38(8):575-80. PubMed ID: 3631642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pentoxifylline on microvascular blood flow velocity.
    Ohshima N; Sato M
    Angiology; 1981 Nov; 32(11):752-63. PubMed ID: 7325410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte deformability in canine septic shock and the efficacy of pentoxifylline and a leukotriene antagonist.
    Puranapanda V; Hinshaw LB; O'Rear EA; Chang AC; Whitsett TL
    Proc Soc Exp Biol Med; 1987 Jun; 185(2):206-10. PubMed ID: 3554261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of hemorheologically active treatment with pentoxifylline in patients with cerebrovascular disease.
    Schneider R
    Angiology; 1989 Nov; 40(11):987-93. PubMed ID: 2817522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes and relationships of erythrocyte flexibility and whole blood viscosity of normo-osmolar and hyperosmolar erythrocyte suspensions influenced by 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Leonhardt H; Grigoleit HG; Reinhardt I
    Vasa; 1977; 6(4):316-20. PubMed ID: 930285
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of various drugs (flunixin, pentoxifylline, enoxaparin) modulating micro-rheological changes in cerulein-induced acute pancreatitis in the rat.
    Szentkereszty Z; Kotan R; Kiss F; Klarik Z; Posan J; Furka I; Sapy P; Miko I; Peto K; Nemeth N
    Clin Hemorheol Microcirc; 2014; 57(4):303-14. PubMed ID: 23364024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
    Dormandy JA; Goyle KB
    Br J Surg; 1976 Aug; 63(8):661-2. PubMed ID: 953495
    [No Abstract]   [Full Text] [Related]  

  • 37. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of hexobendine and pentoxifylline on the viscosity of erythrocyte suspension].
    Winkler R; Moser M
    Wien Klin Wochenschr; 1983 Mar; 95(6):209-13. PubMed ID: 6880203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B; Doppelfeld E
    Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.